Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. (3rd July 2018)

Record Type:: Journal Article
Title:: Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. (3rd July 2018)
Main Title:: Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer
Authors:: Overman, M J
Adam, L
Raghav, K
Wang, J
Kee, B
Fogelman, D
Eng, C
Vilar, E
Shroff, R
Dasari, A
Wolff, R
Morris, J
Karunasena, E
Pisanic, T R
Azad, N
Kopetz, S
Abstract:
Is Part Of:: Annals of oncology. Volume 30:Number 3(2019)
Journal:: Annals of oncology
Issue:: Volume 30:Number 3(2019)
Issue Display:: Volume 30, Issue 3 (2019)
Year:: 2019
Volume:: 30
Issue:: 3
Issue Sort Value:: 2019-0030-0003-0000
Page Start:: 495
Page End:: 495
Publication Date:: 2018-07-03
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy221 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12002.xml